However, Akt inhibitor Deguelin (500 nM), mTOR inhibitor Rapamycin (100 nM), and Notch inhibitor RO4929097 (10 μM) had no significant effect on cell proliferation in Lv-control treated pancreatic cancer cells. Here, AKT1 is linked to pancreatic neoplasm.